ES402140A1 - Orally applicable contrast agents for cholecystography - Google Patents

Orally applicable contrast agents for cholecystography

Info

Publication number
ES402140A1
ES402140A1 ES402140A ES402140A ES402140A1 ES 402140 A1 ES402140 A1 ES 402140A1 ES 402140 A ES402140 A ES 402140A ES 402140 A ES402140 A ES 402140A ES 402140 A1 ES402140 A1 ES 402140A1
Authority
ES
Spain
Prior art keywords
radical
alkyl
group
see formula
triiodo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES402140A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco SpA
Original Assignee
Bracco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco SpA filed Critical Bracco SpA
Publication of ES402140A1 publication Critical patent/ES402140A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Procedure for the preparation of the new 3 - [(3-carbamoyl-2,4,6-triiodo-phenoxy) -alkoxy] -2-alkyl-propionic acids capable of being used as shade providing components in ray contrast agents x of the general formula ** (see formula) ** In which alkyl means a lower alkyl group with 1 to a maximum of 4 carbon atoms, but the radical ** (see formula) ** Also means morpholino, piperidino or pyrrolidino group, n means an integer of 2, 3 or 4, and a means the methyl, ethyl, propyl or butyl radical, as well as their physiologically compatible physiological and metal salts, characterized in that ether 3-carbamoyl-2,4,6-triiodo-phenol of the general formula ** (see formula) ** In which alkyl means a lower alkyl group with 1 up to a maximum of 4 carbon atoms, but the radical ** (see formula) ** Also means a morpholino, piperidino, or pyrrolidino group, by reaction with a 3-alkoxy-2-alkyl-propionic acid derivative capable of reacting of the general formula ** (see formula) ** Wherein x means the reactive radical of a strong acid, therefore a halogen, chloro, bromo or iodo radical, or a radical sulfate or sulfonate, n means an integer of 2.3 or 4, a, means a group methyl, ethyl, propyl or butyl and -coor'means a carboxylic acid ester group or a carboxylate group, and subsequently the corresponding acid 3 - [(3-carbamoyl-2,4,6-triiodo-phenoxy) - is isolated alkoxy] -2-alkyl-propionic and eventually it is transformed into its salts. (Machine-translation by Google Translate, not legally binding)
ES402140A 1971-06-23 1972-04-26 Orally applicable contrast agents for cholecystography Expired ES402140A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH914771 1971-06-23

Publications (1)

Publication Number Publication Date
ES402140A1 true ES402140A1 (en) 1975-03-01

Family

ID=4348851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES402140A Expired ES402140A1 (en) 1971-06-23 1972-04-26 Orally applicable contrast agents for cholecystography

Country Status (26)

Country Link
US (1) US3825591A (en)
JP (1) JPS529666B1 (en)
AT (2) AT315150B (en)
AU (1) AU461847B2 (en)
BE (1) BE785109R (en)
BG (1) BG20336A3 (en)
BR (1) BR7204002D0 (en)
CA (1) CA957371A (en)
CH (1) CH545628A (en)
CS (1) CS182769B2 (en)
DD (1) DD95912A5 (en)
DE (1) DE2212741C3 (en)
DK (1) DK128108B (en)
ES (1) ES402140A1 (en)
FI (1) FI53660C (en)
FR (1) FR2142986B1 (en)
HU (1) HU163382B (en)
IL (1) IL39329A (en)
IT (1) IT7921397A0 (en)
NL (1) NL157798B (en)
PH (1) PH10571A (en)
PL (1) PL90341B1 (en)
RO (1) RO68261A (en)
SE (1) SE391178B (en)
SU (1) SU451237A3 (en)
ZA (1) ZA723058B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164618D1 (en) 1980-12-22 1984-08-09 Schering Ag 3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5348727A (en) * 1993-03-11 1994-09-20 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers for visualization of the gastrointestinal tract
US5492687A (en) * 1993-03-11 1996-02-20 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5472682A (en) * 1993-03-31 1995-12-05 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US6051210A (en) 1997-05-15 2000-04-18 Bracco Research Usa N,N-dimethyldiatrizoic acid and its conjugates as hepatobiliary agents for X-ray CT imaging

Also Published As

Publication number Publication date
AU461847B2 (en) 1975-06-05
JPS529666B1 (en) 1977-03-17
DD95912A5 (en) 1973-02-20
FR2142986A1 (en) 1973-02-02
FI53660C (en) 1978-07-10
DE2212741C3 (en) 1974-06-12
BG20336A3 (en) 1975-11-05
DE2212741A1 (en) 1972-12-28
HU163382B (en) 1973-08-28
FR2142986B1 (en) 1976-04-16
AT313469B (en) 1974-02-25
US3825591A (en) 1974-07-23
AT315150B (en) 1974-05-10
SU451237A3 (en) 1974-11-25
CA957371A (en) 1974-11-05
CS182769B2 (en) 1978-05-31
RO68261A (en) 1981-11-04
IL39329A (en) 1975-04-25
PL90341B1 (en) 1977-01-31
NL7205712A (en) 1972-12-28
BR7204002D0 (en) 1973-11-01
PH10571A (en) 1977-06-30
NL157798B (en) 1978-09-15
IL39329A0 (en) 1972-07-26
DK128108B (en) 1974-03-04
SE391178B (en) 1977-02-07
ZA723058B (en) 1973-02-28
AU4371672A (en) 1974-01-03
CH545628A (en) 1974-02-15
BE785109R (en) 1972-12-19
IT7921397A0 (en) 1979-03-28
FI53660B (en) 1978-03-31
DE2212741B2 (en) 1973-11-08

Similar Documents

Publication Publication Date Title
ES402140A1 (en) Orally applicable contrast agents for cholecystography
ES323305A1 (en) Procedure for the preparation of 1-aralquil-4- (tiazolil2) -piperacinas. (Machine-translation by Google Translate, not legally binding)
JPS5278848A (en) Preparation of novel propionic acid ester derivatives
ES404592A1 (en) 2,3-dihydro-oxo-imidazo(1,2-a)pyrimidines and salts thereof
ES419871A1 (en) Aroyl-substituted phenylacetic acid derivatives
ES385586A1 (en) Substituted n aminoalkyl arylamino imidazolines-(2)
GB1382887A (en) Thiazole-5-carboxylic acid esters
ES408615A1 (en) Novel oxazolidone derivatives and preparation thereof
ES459230A1 (en) Esters of testo-sterone and 5 -dihydro-testosterone
ES395599A1 (en) Orally administered contrast agents for cholecystography
ES378368A1 (en) 2-5,-nitro-2,-imidazolyl-benzimidazoles
ES381581A1 (en) Hexahydro-fluoren-2-yloxy alkanoic acids and esters thereof
ES441341A1 (en) 4-oxo-4h-pyrano(3,2-c)quinoline-2-carboxylic acids and salts thereof
ES405648A1 (en) Procedure for the preparation of new acids 4- (4 bifenilil) -4-hydroxy-butirrics, its esteres or lactonas. (Machine-translation by Google Translate, not legally binding)
ES425216A1 (en) Substituted triazolo-1,5-benzodiazepines
GB1313479A (en) Monocarboxylic acid esters of polyethylene glycol ethers
GB1321407A (en) 1-phenyl-4-amino-cyclohex-2-ene-1-carboxylic acid esters
ES436218A1 (en) Phenoxyalkanol derivatives and a process for their preparation
ES436157A1 (en) A procedure for the preparation of indoline compounds. (Machine-translation by Google Translate, not legally binding)
ES388787A1 (en) Substituted quinoxaline-di oxides and process of preparation thereof
ES418841A1 (en) Derivatives of pyridine-3-acetic acid
ES404787A1 (en) Substituted xanthone carboxylic acid compounds
ES400163A1 (en) Novel pregnanoic acid derivatives
ES406126A1 (en) Procedure for the preparation of 4- (4-bifenilil) -butirrics and their steres. (Machine-translation by Google Translate, not legally binding)
ES378236A1 (en) 3-(5-nitro-2-imidazolyl-methylenamino)-2-oxazolidinones